Magnetic Nanoparticle-Modified Cells for Ocular Tissue Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering cells to specific tissues, such as those in the eye, are inefficient due to lack of localization control, leading to cells not properly attaching or being incorporated, especially in invasive procedures like transplantation for eye diseases.
Innovation Solution
Affixing magnetic nanoparticles with diameters of 200 nm or less to the surface of cells using cell-specific binding agents and applying an external magnetic field to direct the cells to target tissues within the body.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cells are injected into the body without magnetic targeting, then the procedure is simple and non-invasive, but the cells do not remain localized and fail to attach to or incorporate into the target tissue
Solution Approach 1:
Magnetic particles serve as an intermediary between the external magnetic field and the cells. These particles are attached to the cell surface and respond to magnetic fields, enabling remote control of cell localization without direct mechanical intervention. The particles mediate the interaction between the magnetic field gradient and the cell, allowing precise positioning in the target tissue.
Solution Approach 2:
The patent replaces mechanical surgical procedures (such as incisions, sutures, and direct tissue manipulation) with a magnetic field-based system. Instead of physically implanting cells through invasive surgery, the magnetic field guides and retains cells at the target site, substituting mechanical control with magnetic field control for cell positioning and retention.
2Force
If larger magnetic particles are used for cell targeting, then the magnetic effect is stronger, but the particles can clog ocular outflow and raise intraocular pressure
Solution Approach 1:
The patent changes the size parameter of magnetic particles from micrometer scale to nanometer scale (500 nm or less, preferably 200 nm or less). This parameter change maintains sufficient magnetic responsiveness while eliminating the harmful effect of particle size on ocular outflow. The nanoscale dimensions allow particles to be small enough to pass through ocular filters without clogging, yet large enough to exhibit useful magnetic properties.
Solution Approach 2:
The patent applies different size requirements to different locations and functions: larger particles (micrometer scale) may be used for applications where strong magnetic retention is needed and clogging is not a concern, while smaller particles (nanometer scale) are used specifically for ocular applications where particles must pass through narrow outflow pathways. This local quality adjustment optimizes both magnetic effectiveness and safety for each specific application site.
3Reliability
If whole tissue transplants are performed, then cell delivery is effective, but the procedure is highly invasive with varying success rates
Solution Approach 1:
The patent segments the transplant procedure into two separate components: (1) harvesting and preparing cells in vitro under controlled conditions, and (2) delivering the isolated cells to the target site using magnetic targeting. This segmentation eliminates the need for complex whole-tissue transplantation surgery while maintaining therapeutic effectiveness. Cells can be prepared separately and then precisely delivered to the needed location.
Solution Approach 2:
The patent extracts the essential therapeutic element (viable cells) from the complex whole-tissue transplant procedure. By isolating and using only the cellular component rather than entire tissues, the procedure becomes less invasive while retaining the cell replacement therapy benefits. The magnetic targeting system then delivers these extracted cells precisely to the target site without requiring extensive surgical intervention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise delivery and attachment of cells to specific tissues, reducing the need for whole tissue transplants and minimizing systemic toxicity, while allowing for the use of smaller particles that can be excreted without clogging ocular outflow, thus preventing intraocular pressure issues.
Implementation Method 1
applying a magnetic field to said target tissue thereby delivering said magnetic nanoparticle-comprising cell to specific regions of said target tissue
Implementation Method 2
the magnetic attraction of iron-endocytosed rabbit corneal endothelial cells (RCEC) to Descemet's membrane
Data Source
Figure 1A~1B
Figure 2
AI summary
Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for treatment of disease and/or injury.